SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

BB-Meanwhile, as I wrote ..., I think

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
HDGabor Member Profile
 
Followed By 44
Posts 5,327
Boards Moderated 1
Alias Born 10/07/13
160x600 placeholder
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... "GlobeNewswire Inc." - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... "GlobeNewswire Inc." - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... "GlobeNewswire Inc." - 11/13/2017 6:00:00 AM
Amarin to Present at the Jefferies London Healthcare Conference "GlobeNewswire Inc." - 11/7/2017 6:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/1/2017 6:35:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2017 6:31:37 AM
Amarin Reports Third Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 11/1/2017 5:30:00 AM
Amarin to Report Third Quarter 2017 Results and Host Conference Call on November 1, 2017 "GlobeNewswire Inc." - 10/25/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/6/2017 7:23:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:02 PM
Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada "GlobeNewswire Inc." - 9/25/2017 6:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 9/22/2017 1:08:41 PM
Amarin to Present at Cantor Global Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 4:30:00 PM
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer "GlobeNewswire Inc." - 9/13/2017 6:00:00 AM
Amarin to Present at Rodman & Renshaw’s Global Investment Conference "GlobeNewswire Inc." - 9/6/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 4:02:36 PM
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... "GlobeNewswire Inc." - 8/14/2017 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/2/2017 5:06:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2017 6:38:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 6:31:46 AM
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 8/2/2017 5:30:00 AM
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 "GlobeNewswire Inc." - 7/26/2017 4:30:00 PM
HDGabor   Friday, 10/06/17 09:59:59 AM
Re: Biobillionair post# 115635
Post # of 119110 
BB-

Meanwhile, as I wrote ..., I think the ITC has jurisdiction and I do not think that Amarin will fail in case of an investigation, but I do not have any idea what you mean by "FDA can’t afford an ITC failure". None of the outcome of the ITC case (no inc., inv. but no "ban" inv. and "ban") will affect the FDA.
Quote:
If we are wrong we disagree what would happen.

Yeah ... and you disagree with Supreme Court also ...

What's up with the "ANCHOR SPA & Ad Com REDUCE-IT" case / claim?

Best,
G


#NEWMIAMI

Disclosure:
I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Do Your Job
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist